A surgical procedure for performing liposculpture on the human body comprising defining a surgical site where the liposculpture is to be performed including substantially 360 about at least the torso portion of the body and/or the limbs. The surgical site is infiltrated with a predetermined quantity of solution and subsequently performing multi-layer emulsification of fat deposits about the surgical site utilizing technology comprising vibration amplification of sound energy at resonance or (VASER), wherein the multi-layer emulsification includes at least a superficial layer emulsification of fat deposits and a deep layer emulsification of fat deposits. Subsequently, a multi-layer liposuction extraction of the emulsified fat deposits is performed, wherein the multi-layer liposuction extraction comprises a deep layer liposuction; a superficial layer liposuction and an intermediate layer liposuction.

An ultrasonic device for an ultrasound-assisted lipoplasty is provided. The ultrasonic device according to one embodiment of the present disclosure includes: a handpiece; an ultrasonic driving unit provided inside the handpiece; a probe including one end portion connected to the ultrasonic driving unit inside the handpiece and configured to extend outward of the handpiece from the one end portion; and a protection unit formed to extend along a longitudinal direction of the probe and to surround an outer circumferential surface of the probe. A heat-insulation member is provided in at least a portion of an inner circumferential surface of the protection unit.

A bariatric surgery operating room configured and operational for treating metabolic syndrome in human patients on an ambulatory basis. The bariatric surgery operating room includes a set of trocars for creating laparoscopy portals through small incisions formed in a human patient's body while supported upon an operating table. A source of inert gas is provided for infusion into the abdominal region of the patient so as to cause tenting of the abdominal region and abdominal distension and tenting in a human patient suffering from obesity and likely to benefit from visceral fat removal within the body of the human patient. A laparoscope is inserted through a first one of said trocars and into the abdominal region of the human patient so that a surgeon can capture video images of the abdominal region of the patient, and display the captured video images within the view of the surgeon. A powered tissue aspiration instrument is inserted through a second one of the trocars and into the mesenteric region of the human patient. Gripping tools are inserted through a third and optionally fourth trocars installed in the patient's abdomen, for gripping anatomical structures in the mesenteric region during visceral fat tissue aspiration operations. The laparoscope is used to capture video images of the mesenteric region of the human patient during visceral fat tissue aspiration operations, and display video images to provide laparoscopic guidance to the surgeon while aspirating visceral fat tissue from the mesenteric region of the human patient so as to treat metabolic syndrome of the human patient in a minimally-invasive manner by reducing three or more risk factors associated with metabolic syndrome.

A laparoscopic-based method of safely removing visceral fat tissue deposits from within a human patient suffering from metabolic syndrome. Laparoscopy portals are formed through small incisions in a human patient's body, and an inert gas is infused into the abdominal region of the human patient to cause abdominal distension. A laparoscope is inserted into the abdominal region of the human patient so that a surgeon can capture video images of the abdominal region of the patient, and display the captured video images within the view of the surgeon. A powered fat tissue aspiration instrument is inserted into the mesenteric region of the human patient, wherein the powered fat tissue aspiration instrument has an instrument housing and a cannula assembly mounted with respect to the instrument housing. The laparoscope is used to capture video images of the mesenteric region of the human patient, and display the video images to provide laparoscopic guidance to the surgeon while safely aspirating visceral fat tissue from the mesenteric region of the human patient to ameliorate the metabolic syndrome of the human patient on an ambulatory basis.

A minimally invasive fat cell removal system and method is provided using a numbing component, a laser component, and a NIL component. A cannula and fiber of the laser component are insertable into a body of a patient at a biopsy punch to liquefy a fat cell via a tumescent fluid and/or a laser. A NIL cannula of the NIL component is insertable into the body to remove the fat cell via suction and/or nutation. An anesthetic device of the numbing component may reduce sensation of the body where the cannula is insertable. The fat cell may be harvested and implanted at another location of the body.

A twin-cannula fat tissue aspiration instrument system equipped with a hand-supportable fat aspiration instrument having a twin irrigating-type or tumescent-type electro-cauterizing cannula assembly with an inner cannula coupled to a cannula drive mechanism and having an inner aspiration aperture that is reciprocated within an outer cannula having an outer aspiration aperture and being connected to the front portion of the hand-supportable housing, so that said inner cannula reciprocates within said outer cannula when the cannula drive mechanism drives the inner cannula. An irrigation channel is formed along the outer cannula, and in fluid communication with an irrigation aperture formed at the distal portion of the outer cannula and proximate to the outer aspiration aperture. Also, electrodes are disposed about the outer aspiration aperture for delivering RF signals aspirated fat tissue being aspirated through the outer and inner aspiration apertures so as to electro-cauterize said aspirated fat tissue during irrigation operations.

A minimally invasive fat cell removal system and method is provided using a numbing component, a laser component, and a NIL component. A cannula and fiber of the laser component are insertable into a body of a patient at a biopsy punch to liquefy a fat cell via a tumescent fluid and/or a laser. A NIL cannula of the NIL component is insertable into the body to remove the fat cell via suction and/or nutation. An anesthetic device of the numbing component may reduce sensation of the body where the cannula is insertable. The fat cell may be harvested and implanted at another location of the body.

A medical device for treatment for overweight or obesity is presented. The medical device is attached or implanted in patient's target body organs, wherein in each one of the device attachments, or daily in the case of long continuous attachment, the device removes up to 100 grams of energy containing materials from the body. The medical device optionally contains needles or alternatively contains crawling worm-like arm. The energy containing materials may be fat cells, fatty acid molecules driven out from the fat cells or lipids or carbohydrates molecules such as glucose from the blood stream.

A harvesting cannula, including a plurality of ports configured and positioned to improve performance as compared to existing harvesting devices, according to various embodiments, is described herein.

A vibrating hand held surgical instrument for loosening tissue of a patient for liposuction or body contouring procedures. The instrument includes a motor connected to a vibration actuator having an eccentric rotating mass and an end effector for engaging tissue operatively connected to the vibration actuator, wherein the motor rotates the eccentric mass to cause the end effector to vibrate to loosen tissue. A flexible shaft having first end and second ends dampen the vibration to the motor and to the operator handle.